Abstract
A simple, isocratic, rapid and accurate reversed phase high performance liquid chromatography method was developed for the quantitative determination of tazarotene. The developed method is also applicable for the related substance determination in bulk drugs. The chromatographic separation was achieved on a Hypersil C18 (250 mm × 4.6 mm 5 μm) column using water pH 2.5 with orthophosphoric acid:acetonitrile (15:85, v/v) as a mobile phase. The chromatographic resolutions between tazarotene and its potential impurity A and B were found greater than three. The limit of detection and limit of quantification of impurities were found to be 25 and 75 ng mL−1. The percentage recovery of impurities in bulk drug sample was ranged from 96.8 to 103.5.The percentage recovery of tazarotene in bulk drug sample was ranged from 98.4 to 100.9. The developed RPLC method was validated with respect to linearity, accuracy, precision and robustness.
Similar content being viewed by others
References
Tang-Liu DS, Matsumoto RM, Usansky JI (2001) Clin Pharmacokinet 37:273
Chandraratna RA (1996) Br J Dermatol 135(49):18
Slialita AR, Chalker DK, Maloney JM, Miller BH, Tachen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J (1999) Cutis 63(6):349
Attar M, Yu D, Ni J; Yu Z, Ling KH, Tang-Liu DD (2005) J Pharm Sci 94(10):2246
Draft International Harmonisation of Pharmacopoeias (1993) Text on validation of analytical procedures. Pharmaeuropea 5(4):341
ICH, Text on validation of analytical procedures, Q2A
Acknowledgments
We would like to thank management of Veritec Pharma Ltd, Hyderabad, India for donation of drugs.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pathare, D.B., Jadhav, A.S. & Shingare, M.S. A Validated Stability Indicating RPLC Method for Tazarotene. Chroma 66, 247–250 (2007). https://doi.org/10.1365/s10337-007-0265-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-007-0265-z